Vericel Corp
NASDAQ:VCEL

Watchlist Manager
Vericel Corp Logo
Vericel Corp
NASDAQ:VCEL
Watchlist
Price: 59.11 USD 4.23% Market Closed
Market Cap: 2.9B USD
Have any thoughts about
Vericel Corp?
Write Note

Intrinsic Value

The intrinsic value of one VCEL stock under the Base Case scenario is 29.41 USD. Compared to the current market price of 59.11 USD, Vericel Corp is Overvalued by 50%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

VCEL Intrinsic Value
29.41 USD
Overvaluation 50%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation Backtest
Vericel Corp

Backtest Intrinsic Value
Dive into the past to invest in the future

Uncover deeper insights with the Valuation Backtest. Learn how current stock valuations stack up against historical averages to gauge true investment potential.

Start backtest now and learn if your stock is truly undervalued or overvalued!

Run Backtest
Backtest Conclusion
Very Attractive
Current Valuation
+45%
Avg Valuation
-12%
Worst Valuation
-49%
Best Valuation
+45%

Stock is trading at its lowest valuation over the past 5 years.

Backtest Example
Register to View Results
Register to View Results

To access the results of this valuation backtest, please register an account with us. Registration is quick and gives you instant access to insights on 3 stocks per week for free.

Backtest Unavailable

The backtest for VCEL cannot be conducted due to limitations such as insufficient data or other constraints. Please select a different stock or adjust your settings.

Backtest In Progress...
Backtest In Progress...
How do you feel about VCEL?
Bearish
Neutral
Bullish

Fundamental Analysis

Company Quality
No Indicators Selected
Select Indicators

Select up to 3 indicators:

Insider Trading
0-3
Months
0-6
Months
0-12
Months
0-36
Months
No Periods Selected
Select Periods

Select up to 2 periods:

Investment Journal
AI Assistant
AI Assistant
Ask me anything about Vericel Corp

Provide an overview of the primary business activities
of Vericel Corp.

What unique competitive advantages
does Vericel Corp hold over its rivals?

What risks and challenges
does Vericel Corp face in the near future?

Has there been any significant insider trading activity
in Vericel Corp recently?

Summarize the latest earnings call
of Vericel Corp.

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for Vericel Corp.

Provide P/S
for Vericel Corp.

Provide P/E
for Vericel Corp.

Provide P/OCF
for Vericel Corp.

Provide P/FCFE
for Vericel Corp.

Provide P/B
for Vericel Corp.

Provide EV/S
for Vericel Corp.

Provide EV/GP
for Vericel Corp.

Provide EV/EBITDA
for Vericel Corp.

Provide EV/EBIT
for Vericel Corp.

Provide EV/OCF
for Vericel Corp.

Provide EV/FCFF
for Vericel Corp.

Provide EV/IC
for Vericel Corp.

Show me price targets
for Vericel Corp made by professional analysts.

What are the Revenue projections
for Vericel Corp?

How accurate were the past Revenue estimates
for Vericel Corp?

What are the Net Income projections
for Vericel Corp?

How accurate were the past Net Income estimates
for Vericel Corp?

What are the EPS projections
for Vericel Corp?

How accurate were the past EPS estimates
for Vericel Corp?

What are the EBIT projections
for Vericel Corp?

How accurate were the past EBIT estimates
for Vericel Corp?

Compare the revenue forecasts
for Vericel Corp with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of Vericel Corp and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Vericel Corp against its competitors.

Analyze the profit margins
(gross, operating, and net) of Vericel Corp compared to its peers.

Compare the P/E ratios
of Vericel Corp against its peers.

Discuss the investment returns and shareholder value creation
comparing Vericel Corp with its peers.

Analyze the financial leverage
of Vericel Corp compared to its main competitors.

Show all profitability ratios
for Vericel Corp.

Provide ROE
for Vericel Corp.

Provide ROA
for Vericel Corp.

Provide ROIC
for Vericel Corp.

Provide ROCE
for Vericel Corp.

Provide Gross Margin
for Vericel Corp.

Provide Operating Margin
for Vericel Corp.

Provide Net Margin
for Vericel Corp.

Provide FCF Margin
for Vericel Corp.

Show all solvency ratios
for Vericel Corp.

Provide D/E Ratio
for Vericel Corp.

Provide D/A Ratio
for Vericel Corp.

Provide Interest Coverage Ratio
for Vericel Corp.

Provide Altman Z-Score Ratio
for Vericel Corp.

Provide Quick Ratio
for Vericel Corp.

Provide Current Ratio
for Vericel Corp.

Provide Cash Ratio
for Vericel Corp.

What is the historical Revenue growth
over the last 5 years for Vericel Corp?

What is the historical Net Income growth
over the last 5 years for Vericel Corp?

What is the current Free Cash Flow
of Vericel Corp?

Discuss the annual earnings per share (EPS)
trend over the past five years for Vericel Corp.

Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Vericel Corp

Current Assets 190.5m
Cash & Short-Term Investments 101.7m
Receivables 48.5m
Other Current Assets 40.3m
Non-Current Assets 199.9m
Long-Term Investments 32.9m
PP&E 160m
Intangibles 6.4m
Other Non-Current Assets 610k
Current Liabilities 41.3m
Accounts Payable 20.9m
Accrued Liabilities 20.5m
Non-Current Liabilities 91.6m
Long-Term Debt 243k
Other Non-Current Liabilities 91.3m
Efficiency

Earnings Waterfall
Vericel Corp

Revenue
226.8m USD
Cost of Revenue
-64.7m USD
Gross Profit
162.1m USD
Operating Expenses
-163.3m USD
Operating Income
-1.2m USD
Other Expenses
4.8m USD
Net Income
3.5m USD

Free Cash Flow Analysis
Vericel Corp

Last Value
3-Years Average
FCF Margin
Conversion Rate
Fundamental Scores

VCEL Profitability Score
Profitability Due Diligence

Vericel Corp's profitability score is 45/100. The higher the profitability score, the more profitable the company is.

Positive Gross Profit
Exceptional Revenue Growth Forecast
Positive 3-Years Revenue Growth
Negative Free Cash Flow
45/100
Profitability
Score

Vericel Corp's profitability score is 45/100. The higher the profitability score, the more profitable the company is.

VCEL Solvency Score
Solvency Due Diligence

Vericel Corp's solvency score is 85/100. The higher the solvency score, the more solvent the company is.

High Altman Z-Score
Short-Term Solvency
Negative Net Debt
Low D/E
85/100
Solvency
Score

Vericel Corp's solvency score is 85/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

VCEL Price Targets Summary
Vericel Corp

Wall Street analysts forecast VCEL stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for VCEL is 60.56 USD with a low forecast of 56.56 USD and a high forecast of 68.25 USD.

Lowest
Price Target
56.56 USD
4% Downside
Average
Price Target
60.56 USD
2% Upside
Highest
Price Target
68.25 USD
15% Upside
View Analyst Estimates
View Analyst Estimates
Want to learn more about Wall St estimates for VCEL?

Click here to dive deeper.

Dividends

Vericel Corp
does not pay dividends
Shareholder Yield

Current shareholder yield for VCEL is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
No dividends
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Ownership

VCEL Insider Trading
Buy and sell transactions by insiders

Cumulative Transactions Amount
Period Sold Bought Net
3 Months
6 Months
9 Months
12 Months
Why is insider trading important?

Profile

Vericel Corp Logo
Vericel Corp

Country

United States of America

Industry

Biotechnology

Market Cap

2.8B USD

Dividend Yield

0%

Description

Vericel Corp. engages in the research, product development, manufacture, and distribution of patient-specific, expanded cellular therapies for use in the treatment of patients with diseases. The company is headquartered in Cambridge, Massachusetts and currently employs 281 full-time employees. The firm is focused on therapies for the sports medicine and severe burn care markets. The company markets two autologous cell therapy products in the United States, which include MACI (autologous cultured chondrocytes on porcine collagen membrane) and Epicel (cultured epidermal autografts). MACI is an autologous cellularized scaffold product indicated for the repair of symptomatic, single or multiple full-thickness cartilage defects of the knee with or without bone involvement in adults. Epicel is a permanent skin replacement humanitarian use device (HUD) for the treatment of adult and pediatric patients with deep-dermal or full-thickness burns comprising greater than or equal to 30% of total body surface area (TBSA). Its NexoBrid, is a registration-stage, topically administered biological product that enzymatically removes nonviable burn tissue, or eschar, in patients with deep partial and full-thickness thermal burns.

Contact

MASSACHUSETTS
Cambridge
64 Sidney St
+17349305555.0
vcel.com

IPO

1997-02-04

Employees

281

Officers

CEO, President & Director
Mr. Dominick C. Colangelo Esq.
CFO & Treasurer
Mr. Joseph Anthony Mara Jr.
Chief Operating Officer
Mr. Michael Halpin
Chief Legal Officer
Mr. Sean C. Flynn
Chief Medical Officer
Dr. Jonathan M. Hopper FRCSEd., M.B. Ch.B.
Principal Accounting Officer, VP & Corporate Controller
Mr. Jonathan D. Siegal
Show More
Vice President of Finance & Investor Relations
Mr. Eric Burns
Senior Vice President of Corporate Development & Strategy
Mr. Patrick J. Fowler
Vice President of Marketing & Commercial Strategy
Mr. Patrick Helfrich
Senior Vice President of Sales
Mr. Mike Gilligan
Show Less

See Also

Discover More
What is the Intrinsic Value of one VCEL stock?

The intrinsic value of one VCEL stock under the Base Case scenario is 29.41 USD.

Is VCEL stock undervalued or overvalued?

Compared to the current market price of 59.11 USD, Vericel Corp is Overvalued by 50%.

Back to Top